The estimated Net Worth of Jeffrey W Sherman is at least $25.3 Milion dollars as of 27 November 2023. Dr Sherman owns over 5,400 units of Horizon Therapeutics Plc stock worth over $628,020 and over the last 13 years he sold HZNP stock worth over $23,142,958. In addition, he makes $1,553,253 as Exec. VP & Chief Medical Officer at Horizon Therapeutics Plc.
Dr has made over 33 trades of the Horizon Therapeutics Plc stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 5,400 units of HZNP stock worth $10,098 on 27 November 2023.
The largest trade he's ever made was selling 103,842 units of Horizon Therapeutics Plc stock on 7 December 2020 worth over $7,374,859. On average, Dr trades about 10,172 units every 56 days since 2011. As of 27 November 2023 he still owns at least 5,400 units of Horizon Therapeutics Plc stock.
You can see the complete history of Dr Sherman stock trades at the bottom of the page.
Dr. Jeffrey W. Sherman F.A.C.P., FACP, M.D. is the Exec. VP & Chief Medical Officer at Horizon Therapeutics Plc.
As the Exec. VP & Chief Medical Officer of Horizon Therapeutics Plc, the total compensation of Dr D at Horizon Therapeutics Plc is $1,553,253. There are 7 executives at Horizon Therapeutics Plc getting paid more, with Timothy Walbert having the highest compensation of $13,873,200.
Dr D is 66, he's been the Exec. VP & Chief Medical Officer of Horizon Therapeutics Plc since . There are 3 older and 20 younger executives at Horizon Therapeutics Plc. The oldest executive at Horizon Therapeutics Plc is William Daniel, 67, who is the Independent Director.
Jeffrey's mailing address filed with the SEC is C/O XERIS BIOPHARMA HOLDINGS, INC., 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over $454,905,275 worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth $58,823,653 . The most active insiders traders include Jeff Himawan, Woodlands Health Ventures F... oraz Jean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of $12,248,018. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth $351,691.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: